Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
- Conditions
- PregnancyHIV Infection
- Registration Number
- NCT01621347
- Lead Sponsor
- Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- Brief Summary
The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.
- Detailed Description
Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care \& community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 26
- Pregnant Women
- HIV-positive
- Antiretroviral medication delivered in electronical monitors
- Monitored period during pregnancy < 1 month
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in patient adherence during pregnancy and postpartum before delivery (1 to 9 month) and postpartum (6 month) By electronic drug monitoring, pill count and subject interviews' marks
- Secondary Outcome Measures
Name Time Method Adherence barriers and facilitators pregnancy and postpartum (6 months) Data recorded in subject's interview marks
Trial Locations
- Locations (1)
Policlinique Médicale Universitaire
🇨🇭Lausanne, Vaud, Switzerland